drugset / Trial / NCT05840952
A First-in-Human Multi-Part Phase 1 Study in Healthy Volunteers to Evaluate the Safety, Tolerability, Pharmacokinetics, and Drug-Drug Interaction Potential of Single and Multiple Doses of ALG-097558
RandomizedParallel-groupQuadruple-blindTreatment
Summary
A multi-part study of ALG-097558 to evaluate safety, tolerability, pharmacokinetics and drug-drug interaction potential after single and multiple doses in healthy volunteers
Timeline
- Start
- 2023-07-04
- Primary completion
- 2024-04-29
- Completion
- 2024-04-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ALG-097558 | Unknown | — | Oral |
| Subject | Carbamazepine | Small molecule | — | Oral |
| Subject | Itraconazole | Small molecule | — | Oral |
| Subject | Midazolam | Small molecule | — | Oral |